MDMB-FUBICA explained

MDMB-FUBICA is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1]

It was first detected by the EMCDDA in Sweden in February 2015.[2] It is often sold in e-liquid form for use in an electronic cigarette.[3]

Side effects

MDMB-FUBICA's indazole analogue MDMB-FUBINACA has been linked to at least 1000 hospitalisations and 40 deaths as a consequence of intoxication as of March 2015.[4]

Legality

MDMB-FUBICA is banned in Sweden.[5]

See also

Notes and References

  1. Wagmann L, Stiller RG, Fischmann S, Westphal F, Meyer MR . Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases . Archives of Toxicology . 96 . 10 . 2755–2766 . October 2022 . 35788413 . 9352624 . 10.1007/s00204-022-03332-z .
  2. Web site: Hamarosan: 2015. Évi Európai Kábítószer - Jelentés . Coming soon: 2015. Annual European Drugs - Report . Hungarian National Focal Point (NFP) . June 2015 . 23 July 2015.
  3. Peace MR, Krakowiak RI, Wolf CE, Poklis A, Poklis JL . Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes . Forensic Science International . 271 . 92–97 . February 2017 . 28076838 . 5511053 . 10.1016/j.forsciint.2016.12.031 .
  4. Web site: Очередная жертва спайса . Another victim of spice . Federal Drug Control Service of the Russian Federation . 17 March 2015 . 24 July 2015 . https://web.archive.org/web/20150714044651/http://www.fskn.gov.ru/includes/periodics/news/2015/0317/205035975/detail.shtml . 14 July 2015 . dead .
  5. Web site: 23 nya ämnen kan klassas som narkotika eller hälsofarlig vara . 23 new substances can be classified as narcotics or health hazards . Folkhälsomyndigheten (The Public Health Authority) . 1 June 2015 . 24 July 2015.